Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.
Biolchi A, De Angelis G, Moschioni M, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, Claus H, Gorla MCO, Hong E, Lemos APS, Lucidarme J, Taha MK, Vogel U, Comanducci M, Budroni S, Giuliani MM, Rappuoli R, Pizza M, Boucher P.
Biolchi A, et al. Among authors: rappuoli r.
Vaccine. 2020 Nov 3;38(47):7542-7550. doi: 10.1016/j.vaccine.2020.09.050. Epub 2020 Oct 7.
Vaccine. 2020.
PMID: 33036804
Free article.